Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.

about

Application of area scaling analysis to identify natural killer cell and monocyte involvement in the GranToxiLux antibody dependent cell-mediated cytotoxicity assay.

Item

http://www.wikidata.org/entity/Q54263363

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Application of area scaling an ...... l-mediated cytotoxicity assay.

@en

Application of area scaling an ...... l-mediated cytotoxicity assay.

@nl

type

Item

label

Application of area scaling an ...... l-mediated cytotoxicity assay.

@en

Application of area scaling an ...... l-mediated cytotoxicity assay.

@nl

prefLabel

Application of area scaling an ...... l-mediated cytotoxicity assay.

@en

Application of area scaling an ...... l-mediated cytotoxicity assay.

@nl

P1476

Application of area scaling an ...... l-mediated cytotoxicity assay.

@en

P2093

Anthony DeVico

http://www.w3.org/2001/XMLSchema#string

Charles Beck

http://www.w3.org/2001/XMLSchema#string

Chiara Orlandi

http://www.w3.org/2001/XMLSchema#string

George K Lewis

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Justin Pollara

http://www.w3.org/2001/XMLSchema#string

R Whitney Edwards

http://www.w3.org/2001/XMLSchema#string

Richard A Koup

http://www.w3.org/2001/XMLSchema#string

Shan Lu

http://www.w3.org/2001/XMLSchema#string

Shixia Wang

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2

High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Fcgamma receptors as regulators of immune responses

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

P304

436-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CYTO.A.23348

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Ferrari

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29498807

http://www.w3.org/2001/XMLSchema#string

P932

5969088

http://www.w3.org/2001/XMLSchema#string